TWI477269B - 治療口腔乾燥用之牙用組成物 - Google Patents
治療口腔乾燥用之牙用組成物 Download PDFInfo
- Publication number
- TWI477269B TWI477269B TW097133998A TW97133998A TWI477269B TW I477269 B TWI477269 B TW I477269B TW 097133998 A TW097133998 A TW 097133998A TW 97133998 A TW97133998 A TW 97133998A TW I477269 B TWI477269 B TW I477269B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- sulfate
- group
- present
- dental
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 110
- 206010013781 dry mouth Diseases 0.000 title claims description 17
- 239000000551 dentifrice Substances 0.000 title description 2
- 208000005946 Xerostomia Diseases 0.000 title 1
- 239000000606 toothpaste Substances 0.000 claims description 14
- 239000004599 antimicrobial Substances 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 229940034610 toothpaste Drugs 0.000 claims description 13
- 239000002324 mouth wash Substances 0.000 claims description 9
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 7
- 239000011230 binding agent Substances 0.000 claims description 7
- 210000000214 mouth Anatomy 0.000 claims description 7
- 229940051866 mouthwash Drugs 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 208000002925 dental caries Diseases 0.000 claims description 5
- 230000003902 lesion Effects 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 4
- 229940051593 dermatan sulfate Drugs 0.000 claims description 4
- 229920000669 heparin Polymers 0.000 claims description 4
- 229960002897 heparin Drugs 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- 206010017533 Fungal infection Diseases 0.000 claims description 3
- 229920002971 Heparan sulfate Polymers 0.000 claims description 3
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- 208000031888 Mycoses Diseases 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960003260 chlorhexidine Drugs 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 230000007794 irritation Effects 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 229920006184 cellulose methylcellulose Polymers 0.000 claims description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- 208000010362 Protozoan Infections Diseases 0.000 claims 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical group C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 claims 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims 1
- GBCAVSYHPPARHX-UHFFFAOYSA-M n'-cyclohexyl-n-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]methanediimine;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1CCCCC1N=C=NCC[N+]1(C)CCOCC1 GBCAVSYHPPARHX-UHFFFAOYSA-M 0.000 claims 1
- 229940041678 oral spray Drugs 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 20
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 20
- -1 aliphatic quaternary ammonium compound Chemical class 0.000 description 17
- 239000003082 abrasive agent Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002736 nonionic surfactant Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 230000002272 anti-calculus Effects 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229930003270 Vitamin B Natural products 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229940091249 fluoride supplement Drugs 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- CTMBNCSHOCVHMK-UHFFFAOYSA-M 1-pyridin-1-ium-1-ylhexadecan-1-one;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)[N+]1=CC=CC=C1 CTMBNCSHOCVHMK-UHFFFAOYSA-M 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 4
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 4
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 239000004075 cariostatic agent Substances 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Chemical class OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Chemical class 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229940116837 methyleugenol Drugs 0.000 description 2
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000010670 sage oil Substances 0.000 description 2
- 229940084560 sanguinarine Drugs 0.000 description 2
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 2
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Chemical class 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- CJSBVQVTGSIUAN-UHFFFAOYSA-M (2,6-dimethyl-4-phenylheptan-4-yl)-dimethyl-(2-phenoxyethyl)azanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1OCC[N+](C)(C)C(CC(C)C)(CC(C)C)C1=CC=CC=C1 CJSBVQVTGSIUAN-UHFFFAOYSA-M 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical class CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- SUCJSTMOFCKXAK-UHFFFAOYSA-N 1-chlorododecane methanamine Chemical compound NC.CCCCCCCCCCCCCl SUCJSTMOFCKXAK-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ZUGAOYSWHHGDJY-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-aluminabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZUGAOYSWHHGDJY-UHFFFAOYSA-K 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 150000000703 Cerium Chemical class 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 206010048762 Tooth infection Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- MNZHBXZOPHQGMD-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O MNZHBXZOPHQGMD-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 229940124378 dental agent Drugs 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 150000002908 osmium compounds Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000015040 sparkling wine Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical group C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical class [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本發明包含口服組成物,用以治療或預防口乾而有下列優點:抗細菌/抗霉菌功效、低刺激性、與保濕性。該組成物可為牙膏、漱口水或噴劑,且包含如泡沫劑之一種或多種非離子界面活性劑,諸如克羅赫斯汀(chlorhexidine)與氯化十六基吡啶鎓之一種或多種廣效抗微生物劑組成份,與一種或多種口腔表面黏合劑多醣,其可禁閉(encage)陽離子性活性物而有助於在口腔表面上之藥劑沈積及保持且因此提供抗微生物的功效。
口乾,臨床上稱為口腔乾燥,其定義為乾之自覺感受。其主要係由於唾液分泌的減少所引起,然而此種減少的根本的機制依病患而有不同。依照其嚴重性,乾會造成不適且導致諸如齲齒與真菌感染之疾病,特別是腔念珠菌病。
因此,具有雙重腔衛生與乾之預防與治療性質的牙用組成物則有存在之需要,以及有被用作治療該痼疾之能力。
因此,本發明係描述用以舒緩乾之服組成物而有下列抗細菌/抗真菌性質;低刺激性;與保濕之優點。
本發明包含用以治療或預防口乾與至少一種相關聯病變之牙用組成物,其包含一種或多種界面活性劑;一種或多種抗微生物劑,一種或多種黏合劑。該牙用組成物具有口腔衛生處理能力,以及關於口乾、牙周疾病與齲齒之預防疾病效果。
因此在一具體例中,本發明包含一種治療或預防口乾與至少一種相關聯病變之方法,其包含投服受試驗者所需之有效量的口腔照護組成物,該組成物包含一種或多種非離子界面活性劑、一種或多種抗微生物劑、一種或多種黏合劑。
本發明包含抗微生物劑與保濕之組合,其中組成物具有可提供口乾舒緩之性質。令人驚異的是,吾人發現在此所敘述之牙用組成物,係藉由形成似鳥籠構造而可在空間上將陽離子性抗微生物活性物固定化,以維持活性物之生物利用率因而可提供有效率地輸送至口腔黏膜。由於本發明組成物之表面黏合性質與表面塗覆,經改良的黏膜互相作用可提供消費者感知屬性。抗微生物劑在表面之附加的物理性誘捕作用可導致更為實在的效果。
本發明包含用以緩和或預防口腔乾燥(例如口乾)及與口腔疾病之相關聯疾病的牙用組成物。
如在本文所使用者,"牙用劑"係關於餘留於口部相當短時間之產品,其中該等可與實質上所有牙齒表面密切地接觸,其後被移除。該等產品之非限制的例子包含牙膏、預防疾病之糊劑、牙齒磨光劑、凝膠、專業級凝膠與其他相關的專業產品,以及漱口劑、噴劑、漱口水、牙線、口香糖、糖錠(lozenges)、錠劑、食品,等等。
在一具體例中,本發明牙用組成物有牙膏、漱口水、口噴劑、與牙科溶液。在另一具體例中,該組成物為牙膏或漱口水,且在另一具體例中牙用組成物為牙膏。
吾人已發現口腔之口乾與相關聯疾病,包含蛀牙與感染,可以投服口腔照護牙用組成物,其包括一種或多種非離子界面活性劑、一種或多種抗微生物劑、與一種或多種黏合劑多醣來加以治療或預防。
因此,本發明之口腔照護牙用組成物於治療口乾與移除齒菌斑與結石之牙用配方與組成物為有用的。儘管吾人並非意圖適用任何特定原理,然而其顯示口腔照護牙用組成物可徹底地減少甚至停止口乾以及齒菌斑與結石(牙石)增生。吾人亦發現口腔照護牙用組成物可停止齲齒之去礦物質作用,且可消除造成細菌而不至於有害地侵襲口中正常微生物叢之口腔疾病。
本發明之牙用組成物包含一種或多種界面活性劑或適當的界面活性劑之混合物。適當的界面活性劑為該等在廣泛pH範圍下為相當穩定者,例如陰離子性、陽離子性、非離子性或兩性離子性界面活性劑。在一說明性具體例中,界面活性劑係用作泡沫劑之非離子界面活性劑。
適當的界面活性劑在此更詳細說明,例如Agricola等人之美國專利第3,959,458號;Haefele之美國專利第3,937,807號;與Gieske等人之美國專利第4,051,234號,在此併入本文作為參考。
在某些具體例中,在此有用的陰離子性界面活性劑包含在烷基中具有10至18個碳原子之烷基硫酸鹽的水可溶鹽類,與具有10至18個碳原子之脂肪酸的磺化單甘油酯的水可溶鹽類。月桂基硫酸鈉、月桂醯基肌氨酸鈉與椰子(coconut)單甘油酯磺酸鈉為此類型之陰離子性界面活性劑的例子。陰離子性界面活性劑之混合物亦可被使用。
在某些具體例中,本發明包含使用非離子或兩性界面活性劑,諸如替代SLS之普盧蘭尼克(pluronic)中之甜菜碱。該等界面活性劑據報導與對口乾患者有益之SLS比較,其對口腔黏膜有低刺激性。
在另一具體例中,可用於本發明之陽離子性界面活性劑可為脂肪族四級銨化合物之衍生物,該化合物具有包括8至18碳原子之長鏈烷基,諸如氯化月桂基三甲基銨、氯化十六基吡啶鎓、溴化十六基三甲基銨、氯化二異丁基苯氧基乙基二甲基苄基銨、椰子烷基三甲基銨亞硝酸鹽、氟化十六基吡啶鎓、及其混合物。
例示性的陽離子性界面活性劑為揭示於Briner等人之美國專利第3,535,421號之四級銨氟化物,在此併入本文作為參考。
一些陽離子性界面活性劑亦可在組成物中作用為殺菌劑。
可用於本發明組成物中的例示性的非離子性界面活性劑可為藉由烯化氧基團(本質上為親水性)與本質上可為脂肪族或烷基芳香族之有機疏水性化合物縮合所產生之化合物。適當的非離子性界面活性劑包含但不限於,普盧蘭尼克(pluronic)、烷基酚之聚氧化乙烯縮合物、衍自環氧乙烷與環氧丙烷和乙二胺之反應生成物之縮合的產物、脂肪族醇之環氧乙烷縮合物、長鏈三級胺氧化物、長鏈三級膦氧化物、長鏈二烷基亞碸與該等材料之混合物。
在某些具體例中,本發明為有用的兩性離子性合成界面活性劑可為脂肪族四級銨、鏻與鋶化合物之衍生物,其中脂肪族基可為直鏈或分支鏈,且其中脂肪族取代基之一包括8至18碳原子,且其一包括一陰離子性水溶性基,例如羧基、磺酸鹽、硫酸鹽、磷酸鹽或膦酸鹽。適合含於組成物之界面活性劑例示性例子包含但不限於,烷基硫酸鈉、月桂醯基肌胺酸鈉、椰脂醯胺丙基甜菜碱與聚山梨酸酯20、與其組合。
界面活性劑或相容之界面活性劑的混合物可以本發明之組成物之約0.1%至約5.0%之量存在,在另一具體例中為全體組成物之約0.3%至約3.0%,且在另一具體例中為全體組成物之約0.5%至約2.0重量%。
包含於本發明牙用組成物之抗微生物劑與抗菌劑可包含但不限於三氯沙(5-氯-2-(2,4-二氯苯氧基)-酚);克羅赫斯汀;克羅赫斯汀二葡萄糖酸鹽(CHX);阿來西定(alexidine)、雙辛氫啶(HEX);血根鹼(sanguinarine)(SNG);殺藻銨(benzalkonium chloride);柳醛苯胺;杜每芬(domiphen)溴鹽;氯化十六基吡啶鎓(CPC);氯化十四基吡啶鎓(TPC);氯化N-四-癸基-4-乙基吡啶鎓(TDEPC);奧替尼啶;地莫前列素;辛哌醇與其他N-六氫吡啶基衍生物;菸酸(nicin)製劑;鋅/亞錫離子藥劑;諸如安滅菌(augmentin)、安莫西林、四環黴素、去氧四環黴素、美諾四環黴素、與硝基甲嘧唑乙醇之抗生素;諸如過氧化鈰(cylium peroxide)、過氧化氫、與鎂monoperthalate及其類似物之過氧化物;與上述抗微生物劑之類似物與鹽類。
在某些例示性的具體例中可提供一種廣效抗微生物劑之抗真菌特性,那就是CHX與CPC,與特別是抗真菌感染之藥劑,諸如制黴菌素、兩性黴素B、與游黴素。在某些具體例中,組成物與口乾症狀相關聯之細菌感染。
本發明之組成物中之抗微生物劑或抗菌劑係以約0.1%至約5.0%之量存在,在另一具體例中相對於全體組成物為約0.3%至約3.0%之量,且在另一具體例中,為約0.5%至約2.0重量%。
為提供保濕性,其他表面塗覆/保濕聚合物亦可併入於此組成物。該聚合物包含但不限於下列化合物族群:矽酮油(諸如矽靈(dimethicone),已知可提供皮膚照護之表面塗覆與保濕性),與多醣(諸如CMC、黃原膠與卡波莫(Carbopol))、玻尿酸、皮膚素硫酸鹽、軟骨素硫酸鹽、肝素、乙醯肝素硫酸酯與角蛋白硫酸酯。
為了協助例如CHX與CPC,之抗微生物藥劑輸送至口腔表面,在配方成最終組成物之前藉由包膠或預先乳化作用在一個或醣甘胺基聚醣(GAGs)分子基質組合之間,上述兩種化合物在空間上被固定化。該等可與GAG經由電荷間互相作用形成錯合物。GAG-CHX或GAG-CPC錯合物可藉由GAG之高度表面黏合劑性質隨即沈積且留滯於口腔表面上。沈積的錯合物會緩慢地釋放CPC或CHX以提供抗微生物作用。
本發明之組成物中多醣可以約0.1%至約5.0%之量存在,在另一具體例中為全體組成物之約0.3%至約3.0重量%,且在另一具體例中為全體組成物之約0.5%至約2.0重量%。
本發明之牙用組成物之進一步組成份為親水性液體媒劑,包含但不限於甘油、丙二醇、聚乙二醇與諸如三酸甘油酯、甘油二酯之疏水性液體媒劑,與包含礦物油、精油、與脂族蔬菜油之有機油。在此所使用之精油為天然物質,其自各植物性藥物之微小分子囊藉由蒸餾來萃取,且為植物之免疫系統部分而且仍為自植物所製造之尚未分離之物質。蒸餾製程係自植物部分萃取揮發油。此等精油係高度濃縮萃取物,其包括可作用於多種等級之荷爾蒙、維生素與抗菌劑。該等親水性與疏水性液體媒劑可單一使用或組合使用且可被添加於約2至約50重量%之比例(在包含液體媒劑之組成物之情形),尤其是根據全體組成物為約10至約35重量%。
使用該等液體媒液之一種或多種,用於口腔的本發明之組成物中而可配方成為諸如凝膠、液體或糊劑之可用形式。
本發明之牙用組成物亦包括香料組成份,典型為天然香料或芳香油及/或草本精與油類之形式。該等香料組成份不僅可作為供與牙用組成物之令人愉快的香料,同時亦可作用為天然抗細菌劑與防腐劑。本發明之可適用的油類包含但不限於,檸檬油(citric oil)、檸檬油(lemonoil)、酸橙油、香茅油、柳橙油、甜橙油、葡萄油、石榴油、杏仁油精、橘子(tangerine)精、橘欒果油、薄荷油、綠薄荷油、鼠尾草油、迷迭香油、肉桂油、冬青油、丁香油、胺樹油、薑油、黃樟油、薄荷醇、薄荷(arvensis mint)油、合成薄荷香料與油類、藏茴香酮、丁香油酚、甲基丁香油酚、水楊酸甲酯、甲基丁香油酚、百里香酚、大茴香醚、洋蓍草精(Achillea millefolium)、甘菊、薰衣草油、沒藥、丁香油酚、茶樹油、鼠尾草油、錦葵、檸檬油精(limonene)、羅勒烯、正癸基醇、香茅醇、α-香油腦、沈香醇、乙基沈香醇(ethyllinalol)、百里香、杏仁油、肉豆蔻與香草醛。該等香料之一種或該等香料之二種或多種混合物皆可被用於牙用組成物。本發明之牙用組成物中亦可視情況的包括諸如糖精鈉、乙酰磺胺酸(acesulfame)鉀、甘草甜素(glycyrrhizin)、紫蘇油(perillartine)、索馬甜(thaumatin)、天東氨醯基苯基丙氨醯甲基酯與木糖醇的糖精。其內容物根據全體組成物可為約3%至約20重量%量,或約4%至約15重量%。
該牙用組成物可包含一種或多種研磨劑,其可用於本發明之實施例中,包含但不限於,諸如具有平均粒子大小高達約20微米之沈澱二氧化矽的二氧化矽研磨劑,諸如由J. M. Huber公司所販售之Zeodent 115。該研磨劑材料應為一種與本發明重要的組成物相容且並無過度磨損齒質者。適當的研磨劑包含例如,包含凝膠與沈澱物的二氧化矽;不溶性聚偏磷酸鹽、水合氧化鋁、諸如聚合化樹脂(例如尿素、三聚氰胺、交鏈環氧化物、酚類等等)之樹脂製研磨劑及其混合物。
有用的研磨劑亦包含偏磷酸鈉、偏磷酸鉀、磷酸三鈣、二水合磷酸二鈣、矽酸鋁、鍛燒氧化鋁、膠狀黏土或其他矽質材料、或其組合。在此可使用之二氧化矽研磨劑磨光材料,以及其他研磨劑,一般具有約0.1與30微米,5至15微米範圍之平均粒子大小。二氧化矽研磨劑可來自沈澱二氧化矽或二氧化矽凝膠,諸如Pader等人之美國專利第3,538,230號,與Digiulio之美國專利第3,862,307號所揭示之二氧化矽乾凝膠,此兩文獻在此併入本文作為參考。特定之二氧化矽乾凝膠係由W. R. Grace & Co.,Davison Chemical Division公司以商品名Syloid販售。該沈澱二氧化矽材料包含該等J. M. Huber公司以商品名稱Zeodent販售,此Zeodent包含具有指定Zeodent 115與119的二氧化矽。該等二氧化矽磨料係揭示於Wason等人之美國專利第4,340,583號,在此併入本案作為參考。
適用於本發明之附加的二氧化矽研磨劑包含但不限於二氧化矽凝膠、沈澱二氧化矽、矽酸鹽類與水合二氧化矽。適於本發明使用之二氧化矽凝膠有水凝膠、水合凝膠、乾凝膠與氣凝膠,諸如為熟悉該項技藝人士所熟知並揭示於美國專利第6,440,397號者,其在此併入本文作為參考。沈澱二氧化矽係熟悉該項技藝人士所熟知者,諸如揭示於美國專利第5,589,160號之適當的牙用型沈澱二氧化矽,其之內容併入本案作為參考。適當的矽酸鹽類係適於與牙用組成物一起使用之該等天然發生的或合成的矽酸鹽類。該等二氧化矽研磨劑可單獨使用或組合使用。在某些具體例中,與本發明一起使用之二氧化矽研磨劑包含二氧化矽凝膠。該二氧化矽研磨劑可與鈣鹽一起使用或替代鈣鹽組成份。
水可視情況地併入本發明之牙膏組成物中。使用於商業用牙膏製劑之水應被去離子且無有機不純物存在。水在此一般可佔約0%至約40重量%之組成物。
本發明之牙用組成物中亦可視情況的包含抗齲齒劑。抗齲齒劑為水可溶氟離子來源。該等氟離子來源之數目極多且對熟悉該項技藝人士而言為熟知,且包含揭示於美國專利第3,535,421號者,其在此併入本文作為參考。氟離子來源材料包含氟化鈉、氟化鉀、單氟磷酸鈉及其混合物。廣泛種類之氟離子產生材料可作為本發明之組成物中可溶性氟化物之來源。適當的氟離子產生材料之例子則揭示於Briner等人之美國專利第3,535,421號;Parran,Jr.等人之美國專利第4,885,155號,與Widder等人之美國專利第3,678,154號,其揭示在此併入本文作為參考。
代表性的氟離子來源包含但不限於氟化亞錫、氟化鈉、氟化鉀、單氟磷酸鈉、氟矽酸鈉、單氟磷酸鈉(MFP)、氟矽酸銨、以及諸如氟化亞錫與氯化亞錫與其組合的氟化錫類。一些特定的具體例包含氟化亞錫或氟化鈉以及其混合物。
在某些具體例中,本發明之口腔照護的條狀或帶狀口服組成物亦包含氟離子來源或提供氟之組成份,其量可充分地供應約25ppm至5,000ppm的氟離子。
氟離子來源可被添加於本發明之組成物,其量在一具體例中為約0.01%至3.0%,或在另一具體例中為組成物之約0.03%至1.0%之量。個人條狀或(strip)帶狀(tape)劑量(例如單一劑量)為約0.0001至0.003重量%,0.0005至0.003重量%,且在另一具體例中為約0.001至0.02重量%。
本發明之牙用組成物中亦可視情況的包含一種或多種抗結石(抗牙石)藥劑。可用於本發明之牙用組成物中之抗結石藥劑包含諸如克羅赫斯汀、尼達黴素與三氯沙之抗微生物劑,諸如檸檬酸鋅之金屬與金屬鹽類、維生素C、雙膦酸鹽類、三氯沙焦磷酸鹽類、焦磷酸鹽類、聚磷酸鹽類、聚丙烯酸鹽類與其他聚羧酸鹽類、聚環氧基琥珀酸鹽類、乙二胺四醋酸(EDTA)、氮川三醋酸與相關之化合物,諸如六偏磷酸鈉的聚膦酸鹽與聚焦磷酸鹽類,以及其他為熟悉該項技藝人士所熟知之抗結石藥劑,諸如K. J. Fairbrother等人發表於臨床牙周病學月刊Vol.27,pp.285301(2000)的"抗結石藥劑"。
營養物與維生素亦可視情況的添加於本發明之牙用組成物中。此等藥劑可包含葉酸、視黃醇(維生素A)、維生素B(維生素B1
-硫胺素(thiamin)、維生素B2
-核黃素、維生素B3
、維生素B5
-泛酸、維生素B6
-吡哆醇、維生素B7
-維生素H、維生素B8
/B9
/Bc-葉酸、B12
-氰鈷胺酸)、維生素C(抗壞血酸、抗壞血酸鈉)、維生素E、維生素E類似物(消旋-、α-生育酚乙酸酯、生育酚琥珀酸酯、生育酚菸鹼酸酯)與鋅。
各種添加劑亦可視情況的與本發明之牙用組成物一起配製。例如牙齒去敏感劑(諸如鉀與鍶鹽)、諸如四焦磷酸鈉及鉀鹽的濃縮抗牙石劑、諸如氧化鋁與過氧化鈣的增白劑、諸如碳酸氫鈉的清創劑、諸如藍15-C174160、綠7-C174260、紅4-CI12085與40 CI16035、黃115 CI47005:1與5 CI19140、與洋紅5 CI16035)的色素與染料,以及諸如雲母(mica)與發泡酒的添加劑。在與其他視情況的牙用添加物時,可由一種該等組成份,或二種或二種以上該等組成份之混合物,以適於牙用組成物之量作使用。
除了上述之組成份,本發明之牙用組成物中可進而包括多種視情況的組成份與媒液,其一般用在口腔中所使用之製劑,諸如潔齒劑。該等視情況的組成份包含但不限於,如研磨劑、界面活性劑、增稠劑、緩衝劑、濕潤劑、防腐劑、抗生素與抗齲齒劑的組成份。如下列所詳細描述之所有這些添加劑為周知,且對熟悉該項技藝人士為熟知。
本發明之牙用組成物中另一視情況的組成份為濕潤劑。濕潤劑係用以防止諸如牙膏組成物的組成物在暴露於空氣中之硬化,並對口部給予漱口劑與牙膏組成物之潮濕感覺。一些濕潤劑亦可對牙膏與漱口劑組成物給與所需香料之甜味。用於本發明之組成物中之適當濕潤劑包含諸如甘油、山梨醇、木糖醇、聚乙二醇與丙二醇之可食用的多元醇。
緩衝劑為本發明之牙用組成物中另一視情況的組成份。緩衝劑係用以保持組成物之pH於範圍內。用於本發明之牙用組成物中適當的緩衝劑包含可溶性磷酸鹽鹽類。
其他本發明之牙用組成物中視情況的組成份為防腐劑,諸如該等可防止牙用組成物中微生物生長者。適當的防腐劑包含但不限於對羥苯甲酸甲酯、對羥苯甲酸丙酯、苯甲酸、與諸如乙醇的醇類。
黏合劑與增稠劑亦可視情況的用於本發明之牙用組成物中,尤其是在牙膏組成物。在某些具體例中,黏合劑與增稠劑包含但不限於,角叉菜(carrageenan)(例如卡拉膠(Viscarin)、愛爾蘭青苔等等);纖維素衍生物,諸如羥乙基纖維素、羧甲基纖維素鈉、與羧甲基羥丙基纖維素鈉、羧乙烯聚合物;天然樹膠,諸如刺梧桐樹膠,阿拉伯膠與黃芪膠;多醣樹膠,諸如黃原膠;煙燻二氧化矽;與膠體矽酸鎂鋁鹽。
吾人亦令人意外的發現本發明之牙用組成物中具有減低、治療或預防口乾之能力。根據本發明之組成物可藉由塗抹於口腔內並刷洗牙齒及/或齒齦而使用。對此種刷洗,係使用具有齒菌斑移除刷毛(bristles)與齒齦按摩部分之組合的牙刷,傳統牙刷,亦即具有齒菌斑移除刷毛之牙刷或具有按摩部分之牙刷亦可被使用。
例示性的實施例1提供牙膏配方之非限制實施例。下列組成份係以下述之比例組合:
例示性的實施例2提供一種漱口水之非限制實施例配方。下列組成份係以下述之比例組合者。
Claims (10)
- 一種用於治療及/或預防口乾及至少一種相關聯病變之組成物,其包含0.1至3重量%之選自椰脂醯胺丙基(cocoamidopropyl)甜菜鹼的界面活性劑、0.1至5重量%之選自克羅赫斯汀(chlorhexidine,CHX)及氯化十六基吡啶鎓(CPC)的抗微生物劑與0.1至3重量%之至少一種黏合劑,其係基於總組成物之重量,其中該至少一種抗微生物劑係與一或多種醣甘胺基聚醣(GAG)立體地被固定化在複合物中,其中該醣甘胺基聚醣(GAG)選自由玻尿酸(hyaluronic acid)、皮膚素硫酸鹽(dermatan sulfate)、軟骨素硫酸鹽(chondrotin sulfate)、肝素、乙醯肝素硫酸酯(heparin sulfate)與角蛋白硫酸酯(keratin sulfate)所組成之群組。
- 如申請專利範圍第1項之組成物,其中該組成物適合口服。
- 如申請專利範圍第1項之組成物,其中該組成物為牙膏、漱口劑、或口用噴劑。
- 如申請專利範圍第1項之組成物,其中至少一種相關聯病變係選自細菌感染、真菌感染、與原生動物感染。
- 如申請專利範圍第1項之組成物,其中該組成物對口腔有低刺激性。
- 如申請專利範圍第1項之組成物,其中至少一種黏合劑係選自矽酮油、多醣、CMC、黃原膠(xanthan)、卡波姆(carbopol)、玻尿酸(hyaluronic acid)、皮膚素硫酸鹽(dermatan sulfate)、軟骨素硫酸鹽(chondrotin sulfate)、肝素、乙醯肝素硫酸酯(heparin sulfate)與角蛋白硫酸酯(keratin sulfate)。
- 如申請專利範圍第1項之組成物,其中組成物進而包括至少一種表面塗覆/保濕聚合物。
- 如申請專利範圍第1項之組成物,其中組成物進而包括至少一種氟化物來源。
- 如申請專利範圍第1項之組成物,其中至少一種相關聯病變為齲齒(caries)。
- 如申請專利範圍第1項之組成物,其中組成物進而包括至少一種研磨劑。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/850,955 US20090068122A1 (en) | 2007-09-06 | 2007-09-06 | Dentifrice Compositions for Treating Xerostomia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200927183A TW200927183A (en) | 2009-07-01 |
| TWI477269B true TWI477269B (zh) | 2015-03-21 |
Family
ID=39884915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097133998A TWI477269B (zh) | 2007-09-06 | 2008-09-05 | 治療口腔乾燥用之牙用組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090068122A1 (zh) |
| EP (1) | EP2187885A1 (zh) |
| JP (1) | JP2010538074A (zh) |
| CN (1) | CN101795686A (zh) |
| AR (1) | AR068379A1 (zh) |
| AU (1) | AU2008296757C1 (zh) |
| BR (1) | BRPI0813970A2 (zh) |
| CA (1) | CA2690011C (zh) |
| CO (1) | CO6321137A2 (zh) |
| MX (1) | MX2009012775A (zh) |
| MY (1) | MY151338A (zh) |
| RU (1) | RU2452465C2 (zh) |
| TW (1) | TWI477269B (zh) |
| WO (1) | WO2009032406A1 (zh) |
| ZA (1) | ZA200908898B (zh) |
Families Citing this family (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090053267A1 (en) * | 2007-08-20 | 2009-02-26 | Depierro Karen | Dentifrice composition containing silicone oil beads |
| WO2010036427A1 (en) | 2008-06-17 | 2010-04-01 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| US20100022471A1 (en) * | 2008-07-23 | 2010-01-28 | Sage Products Inc. | Oral Moisturizer for Alleviating Dry Mouth |
| WO2011014415A1 (en) * | 2009-07-31 | 2011-02-03 | Colgate-Palmolive Company | High cleaning dentifrice compositions |
| US20110104080A1 (en) * | 2009-11-03 | 2011-05-05 | David Salloum Salloum | Oral Compositions for Treatment of Dry Mouth |
| US20110104081A1 (en) * | 2009-11-03 | 2011-05-05 | Douglas Craig Scott | Oral Compositions for Treatment of Dry Mouth |
| BR112012013193A2 (pt) * | 2009-12-04 | 2016-03-01 | Colgate Palmolive Co | composição oral contendo zizyphus joazeiro e métodos relacionados |
| CA2780324A1 (en) * | 2009-12-04 | 2011-06-09 | Colgate-Palmolive Company | Oral compositions containing a combination of natural extracts and related methods |
| EP2689805A1 (en) * | 2009-12-04 | 2014-01-29 | Colgate-Palmolive Company | Oral compositions containing extracts of garcinia mangostana l. and related methods |
| PH12012500950A1 (en) * | 2009-12-04 | 2013-01-07 | Colgate Palmolive Co | Oral compositions containing extracts of myristica fragrans and related methods |
| MX341274B (es) * | 2010-07-30 | 2016-08-12 | Colgate-Palmolive Company * | Formulaciones de enjuague bucal para ser usadas con un dispositivo de suministro en el cepillo de dientes. |
| BR112013016212B1 (pt) | 2010-12-23 | 2019-01-22 | Colgate-Palmolive Company | composição aquosa de cuidado oral compreendendo goma xantana, goma de celulose e carbômero e uso da referida composição. |
| CN102085369B (zh) * | 2011-01-28 | 2012-07-04 | 武汉耦合医学科技有限责任公司 | 一种口腔干燥症凝胶医疗用品及其制备方法 |
| CA2842462C (en) | 2011-07-20 | 2020-01-28 | Brigham Young University | Hydrogel materials incorporating eluting ceragenin compound |
| US8697036B2 (en) * | 2011-08-02 | 2014-04-15 | The Procter & Gamble Company | Process for surfactant taste and/or odor improvement |
| US9603859B2 (en) | 2011-09-13 | 2017-03-28 | Brigham Young University | Methods and products for increasing the rate of healing of tissue wounds |
| KR101966293B1 (ko) | 2011-09-13 | 2019-04-08 | 브라이엄 영 유니버시티 | 손상조직 치유용 제품 |
| US9694019B2 (en) | 2011-09-13 | 2017-07-04 | Brigham Young University | Compositions and methods for treating bone diseases and broken bones |
| CA2852989C (en) | 2011-09-13 | 2021-06-29 | Brigham Young University | Compositions for treating bone diseases and broken bones |
| GB201121300D0 (en) * | 2011-12-12 | 2012-01-25 | Glaxo Group Ltd | Novel composition |
| US20140363780A1 (en) * | 2011-12-21 | 2014-12-11 | Brigham Young University | Oral care compositions |
| EP3449900A1 (en) * | 2011-12-21 | 2019-03-06 | Brigham Young University | Oral care compositions |
| US9533063B1 (en) | 2012-03-01 | 2017-01-03 | Brigham Young University | Aerosols incorporating ceragenin compounds and methods of use thereof |
| CA2872399C (en) | 2012-05-02 | 2021-01-12 | Brigham Young University | Ceragenin particulate materials and methods for making same |
| US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
| US9724542B2 (en) * | 2012-10-12 | 2017-08-08 | Premier Dental Products Company | Remineralizing and desensitizing compositions, treatments and methods of manufacture |
| CA2888259C (en) | 2012-10-17 | 2019-05-28 | Brigham Young University | Treatment and prevention of mastitis |
| CN105451742B (zh) | 2013-01-07 | 2021-04-06 | 布莱阿姆青年大学 | 减少细胞增殖和治疗某些疾病的方法 |
| US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| US8815952B1 (en) * | 2013-03-15 | 2014-08-26 | Carnell & Herzog, LLC | Chlorhexadine antiseptic |
| US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| CA2907082C (en) | 2013-03-15 | 2021-05-04 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| RU2525660C1 (ru) * | 2013-03-19 | 2014-08-20 | государственное бюджетное образовательное учреждение высшего профессионального образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СтГМУ Минздрава России) | Способ лечения заболеваний пародонта |
| US9387215B2 (en) | 2013-04-22 | 2016-07-12 | Brigham Young University | Animal feed including cationic cholesterol additive and related methods |
| WO2015023226A1 (en) * | 2013-08-16 | 2015-02-19 | Exthera Ab | Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion |
| US20150099010A1 (en) | 2013-10-07 | 2015-04-09 | Reoxcyn Discoveries Group, Inc | Redox signaling gel formulation |
| US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
| US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
| CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
| US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
| US9867836B2 (en) | 2014-03-13 | 2018-01-16 | Brigham Young University | Lavage and/or infusion using CSA compounds for increasing fertility in a mammal |
| US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
| US9686966B2 (en) | 2014-04-30 | 2017-06-27 | Brigham Young University | Methods and apparatus for cleaning or disinfecting a water delivery system |
| US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
| US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
| US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
| US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
| US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
| WO2016172553A1 (en) | 2015-04-22 | 2016-10-27 | Savage Paul B | Methods for the synthesis of ceragenins |
| CZ28634U1 (cs) | 2015-05-05 | 2015-09-14 | Contipro Pharma A.S. | Dentální přípravek na bázi hyaluronanu a oktenidin dihydrochloridu |
| US9434759B1 (en) | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
| US10485827B2 (en) | 2016-01-19 | 2019-11-26 | Rdg Holdings, Inc. | Topical eye serum compositions, methods or preparing, and methods of use |
| CN105748507B (zh) * | 2016-02-26 | 2018-04-17 | 陕西恒远生物科技有限公司 | 一种缓解口腔干燥的凝胶剂 |
| US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
| US9474768B1 (en) | 2016-05-18 | 2016-10-25 | Reoxcyn Discoveries Group, Inc. | Lubricant formulations |
| US11857674B2 (en) | 2016-05-18 | 2024-01-02 | Reoxcyn, Llc | Lubricant formulations |
| KR102677610B1 (ko) | 2016-07-11 | 2024-06-20 | 삼성전자주식회사 | 피리디늄계 복합체, 및 이를 포함하는 성형품 |
| US9833471B1 (en) | 2016-09-15 | 2017-12-05 | Reoxcyn Discoveries Group, Inc. | Hypochlorous acid-based hand sanitizer |
| CA3039117A1 (en) * | 2016-10-17 | 2018-04-26 | Colgate-Palmolive Company | Oral care composition having enhanced appearance and form |
| US20180200165A1 (en) | 2017-01-16 | 2018-07-19 | Reoxcyn Innovation Group, Llc | Dentifrice formulations and methods of oral care |
| EP3366272B1 (en) * | 2017-02-28 | 2019-10-30 | Unilever PLC | Oral care compositions |
| US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
| JP7455317B2 (ja) * | 2017-06-30 | 2024-03-26 | 小林製薬株式会社 | 口腔用組成物 |
| IE87094B1 (en) * | 2017-08-04 | 2020-05-13 | Laboratorios Kin S A | Gel comprising chlorhexidine |
| CN109381364A (zh) * | 2017-08-09 | 2019-02-26 | 杭州孚乐西生物技术有限公司 | 一种含血根碱的牙膏 |
| US11116220B2 (en) | 2017-12-22 | 2021-09-14 | Ecolab Usa Inc. | Antimicrobial compositions with enhanced efficacy |
| CN110787078A (zh) * | 2018-08-20 | 2020-02-14 | 惠州市九惠制药股份有限公司 | 一种含有甘草黄酮的牙膏及其制备方法和应用 |
| JP7140636B2 (ja) * | 2018-11-02 | 2022-09-21 | アース製薬株式会社 | 口腔用薬液噴霧製品 |
| CN113226287B (zh) * | 2018-12-29 | 2025-10-17 | 舒万诺知识产权公司 | 口腔制品及使用方法 |
| MX2021011355A (es) * | 2019-03-18 | 2021-10-13 | Sunstar Americas Inc | Composicion para cuidado oral. |
| EP3952827B1 (en) * | 2019-04-10 | 2025-05-07 | Black Tulip Management, Inc. | Oral rinse compositions for reducing pathogens underlying and for treating periodontal disease and oral malodor in the canine |
| EP3958983A1 (en) | 2019-04-26 | 2022-03-02 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
| US12186328B2 (en) | 2019-05-23 | 2025-01-07 | Brigham Young University | Use of CSA compounds to stimulate stem cells and hair growth |
| BR112021024271A2 (pt) * | 2019-06-14 | 2022-01-11 | Procter & Gamble | Composições para tratamento bucal sem enxágue |
| WO2020248239A1 (en) * | 2019-06-14 | 2020-12-17 | The Procter & Gamble Company | Leave-on oral care compositions |
| EP3982917A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
| WO2020248232A1 (en) * | 2019-06-14 | 2020-12-17 | The Procter & Gamble Company | Leave-on oral care compositions |
| EP3982912A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
| CN110840312B (zh) * | 2019-11-27 | 2021-05-11 | 铜陵麟安生物科技有限公司 | 一种抗菌杀毒的超柔地板湿巾及其制备方法 |
| WO2021167845A1 (en) | 2020-02-18 | 2021-08-26 | Sunstar Americas, Inc. | Oral care composition |
| CN111662616A (zh) * | 2020-07-09 | 2020-09-15 | 周红岩 | 一种热固性树脂组合物及其应用 |
| RU2761303C1 (ru) * | 2021-03-15 | 2021-12-07 | Общество с ограниченной ответственностью "Дубна-Биофарм". | Способ получения фармацевтической композиции и фармацевтическая композиция для лечения и профилактики заболеваний пародонта |
| DE102021108264A1 (de) | 2021-03-31 | 2022-10-06 | G. Pohl-Boskamp Gmbh & Co. Kg | Zusammensetzung zur topischen Anwendung an einem Subjekt |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3678154A (en) * | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
| US3535421A (en) * | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
| US3959458A (en) * | 1973-02-09 | 1976-05-25 | The Procter & Gamble Company | Oral compositions for calculus retardation |
| US3937807A (en) * | 1973-03-06 | 1976-02-10 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| US3862307A (en) * | 1973-04-09 | 1975-01-21 | Procter & Gamble | Dentifrices containing a cationic therapeutic agent and improved silica abrasive |
| US4051234A (en) * | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| US4233288A (en) * | 1979-03-12 | 1980-11-11 | Cornell John A | Gum emulsified liquid package for delivering and preserving liquid content in the mouth |
| US4340583A (en) * | 1979-05-23 | 1982-07-20 | J. M. Huber Corporation | High fluoride compatibility dentifrice abrasives and compositions |
| US4885155A (en) * | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| US4945087A (en) * | 1988-03-31 | 1990-07-31 | Warner-Lambert Company | Taste masking of thymol |
| SE9101076L (sv) * | 1991-04-10 | 1992-10-11 | Camurus Ab | Saliversaettningsmedel |
| US5541165A (en) * | 1994-09-27 | 1996-07-30 | Turgeon; Jean A. | Saliva substitute |
| US6159459A (en) * | 1995-05-01 | 2000-12-12 | Colgate Palmolive Company | Oral lubricating composition |
| US5589160A (en) * | 1995-05-02 | 1996-12-31 | The Procter & Gamble Company | Dentifrice compositions |
| US5658554A (en) * | 1995-06-01 | 1997-08-19 | Colgate-Palmolive Company | Mouth moistener for the relief of dry mouth condition |
| US6294155B1 (en) * | 1998-04-08 | 2001-09-25 | W. R. Grace & Co. -Conn. | Abrasive silica compositions and dentifrice compositions prepared therefrom |
| US6113629A (en) * | 1998-05-01 | 2000-09-05 | Micrus Corporation | Hydrogel for the therapeutic treatment of aneurysms |
| EP1123695A3 (en) * | 2000-01-28 | 2001-09-26 | Unilever N.V. | Oral composition comprising capsules containing keratin |
| ES2186569B1 (es) * | 2001-09-28 | 2004-09-16 | Lacer, S.A. | Composiciones para el alivio de la xerostomia y el tratamiento de los trastornos asociados con la misma. |
| US6579513B1 (en) * | 2002-01-03 | 2003-06-17 | Playtex Products, Inc. | Hygiene mouthspray composition |
| RU2220729C2 (ru) * | 2002-01-31 | 2004-01-10 | Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" | Гелевая композиция, используемая в стоматологии |
| EP1539193A4 (en) * | 2002-07-03 | 2010-05-05 | Pericor Science Inc | HYALURONIC ACID COMPOSITIONS AND METHODS OF USE |
| MX2007001384A (es) * | 2004-08-02 | 2007-04-19 | Glaxo Group Ltd | Novedosa composicion para xerostomia. |
| JP4836227B2 (ja) * | 2005-03-30 | 2011-12-14 | Nsファーファ・ジャパン株式会社 | 口腔内乾燥防止および口腔内刺激緩和用組成物 |
| ITBO20050388A1 (it) * | 2005-06-06 | 2006-12-07 | Alfa Wassermann Spa | Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche |
| RU2286764C1 (ru) * | 2005-06-16 | 2006-11-10 | Георгий Георгиевич Ростиашвили | Средство "гиалудент" пролонгированного действия для лечения воспалительных заболеваний полости рта |
-
2007
- 2007-09-06 US US11/850,955 patent/US20090068122A1/en not_active Abandoned
-
2008
- 2008-07-17 CN CN200880106037A patent/CN101795686A/zh active Pending
- 2008-07-17 RU RU2010112987/15A patent/RU2452465C2/ru active
- 2008-07-17 EP EP08781951A patent/EP2187885A1/en not_active Withdrawn
- 2008-07-17 CA CA2690011A patent/CA2690011C/en not_active Expired - Fee Related
- 2008-07-17 AU AU2008296757A patent/AU2008296757C1/en not_active Ceased
- 2008-07-17 WO PCT/US2008/070285 patent/WO2009032406A1/en not_active Ceased
- 2008-07-17 JP JP2010524069A patent/JP2010538074A/ja active Pending
- 2008-07-17 MY MYPI20094907 patent/MY151338A/en unknown
- 2008-07-17 BR BRPI0813970-9A2A patent/BRPI0813970A2/pt not_active IP Right Cessation
- 2008-07-17 MX MX2009012775A patent/MX2009012775A/es not_active Application Discontinuation
- 2008-09-05 AR ARP080103882A patent/AR068379A1/es unknown
- 2008-09-05 TW TW097133998A patent/TWI477269B/zh not_active IP Right Cessation
-
2009
- 2009-12-14 ZA ZA2009/08898A patent/ZA200908898B/en unknown
- 2009-12-23 CO CO09147466A patent/CO6321137A2/es not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. June 1991, Vol. 35, No. 6, p.1108-1111 Remington: The Science and practice of pharmacy. 21st Edition, 2005, p.891、1030 Pharmaceutical Development and Technology. 2002, Vol. 7, No. 1, p. 1-32 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009012775A (es) | 2009-12-10 |
| RU2452465C2 (ru) | 2012-06-10 |
| AR068379A1 (es) | 2009-11-11 |
| AU2008296757B2 (en) | 2011-06-23 |
| CO6321137A2 (es) | 2011-09-20 |
| CA2690011A1 (en) | 2009-03-12 |
| AU2008296757C1 (en) | 2012-02-02 |
| MY151338A (en) | 2014-05-15 |
| BRPI0813970A2 (pt) | 2015-01-06 |
| EP2187885A1 (en) | 2010-05-26 |
| WO2009032406A1 (en) | 2009-03-12 |
| RU2010112987A (ru) | 2011-10-20 |
| JP2010538074A (ja) | 2010-12-09 |
| CN101795686A (zh) | 2010-08-04 |
| US20090068122A1 (en) | 2009-03-12 |
| TW200927183A (en) | 2009-07-01 |
| AU2008296757A1 (en) | 2009-03-12 |
| ZA200908898B (en) | 2014-11-26 |
| CA2690011C (en) | 2015-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI477269B (zh) | 治療口腔乾燥用之牙用組成物 | |
| JP5191985B2 (ja) | 増強された白化及び染み予防を提供する口腔ケア組成物 | |
| US20010006624A1 (en) | Oral care compositions comprising chlorite and methods | |
| EP3883538B1 (en) | Reduction of pathogenic bacteria using arginine | |
| AU2016344348B2 (en) | Mouthwash products and methods | |
| TW201622693A (zh) | 含矽石與檸檬酸鋅之口腔護理組成物 | |
| US11471394B2 (en) | Oral care compositions containing deoxy sugar antimetabolites | |
| US7087219B2 (en) | Toothpaste containing anticancer agents | |
| JP2004500377A (ja) | 改良型低コスト歯磨き剤組成物 | |
| US8778312B2 (en) | Densensitizing dentifrice exhibiting dental tissue antibacterial agent uptake | |
| US20230390185A1 (en) | Oral care products and methods | |
| US20060246016A1 (en) | Toothpaste containing anticancer agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |